# Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients

> **NCT02724956** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 53 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DEVICE:** Ambu AuraGain
- **DEVICE:** Teleflex LMA Protector
- **DEVICE:** Ambu aScope

## Key facts

- **NCT ID:** NCT02724956
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2020-12-18
- **Final completion:** 2020-12-18
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2021-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02724956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02724956, "Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02724956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*